$16.59
0.201.22%
Last update: Oct 23, 4:00 PM
NeoGenomics Inc (NEO) Stock Price, Quote, News & History
NEONASDAQ
NeoGenomics stock falls after leadership shuffle and Q3 preliminary results. Analysts weigh in on growth and valuation.
You can purchase shares of NeoGenomics (NASDAQ:NEO) through any online brokerage.
Other companies in NeoGenomics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
NeoGenomics has a consensus price target of $17.29.
The stock price for NeoGenomics (NASDAQ: NEO) is $16.59 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for NeoGenomics.
NeoGenomics does not have any upcoming earnings scheduled.
There is no upcoming split for NeoGenomics.
NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and...
